Cited by 2,150Pancreatic and Hepatic Oncology ResearchCancer Cells and MetastasisPancreatic function and diabetes

Organoid models of human and mouse ductal pancreatic cancer

Open access
Boj, Sylvia F., Hwang, Chang-Il, Baker, Lindsey A., Chio, Iok In Christine, Engle, Dannielle D., Corbo, Vincenzo, Jager, Myrthe, Ponz-Sarvise, Mariano +40 more·2015·Cell

Abstract

Pancreatic cancer is one of the most lethal malignancies due to its late diagnosis and limited response to treatment. Tractable methods to identify and interrogate pathways involved in pancreatic tumorigenesis are urgently needed. We established organoid models from normal and neoplastic murine and human pancreas tissues. Pancreatic organoids can be rapidly generated from resected tumors and biopsies, survive cryopreservation, and exhibit ductal- and disease-stage-specific characteristics. Orthotopically transplanted neoplastic organoids recapitulate the full spectrum of tumor development by forming early-grade neoplasms that progress to locally invasive and metastatic carcinomas. Due to their ability to be genetically manipulated, organoids are a platform to probe genetic cooperation. Comprehensive transcriptional and proteomic analyses of murine pancreatic organoids revealed genes and pathways altered during disease progression. The confirmation of many of these protein changes in human tissues demonstrates that organoids are a facile model system to discover characteristics of this deadly malignancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2014.12.021

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Significant differences in morphology, functionality, or organoid formation efficiency depend on the cells-of-origin, different cells in the organoid, and medium composition.

    “Significant differences in morphology and functionality or even organoid formation efficiency depend on the different cells-of-origin of the culture or different cells in the organoid as well as different medium composition120,202–204.”

    From Organoids (2022) · cites this paper as [202]

    The Results section on human pancreatic organoids (page not provided) reports different morphologies and growth-factor requirements for normal and tumor-derived organoids, supporting differences associated with tissue source and medium composition. It does not show that different cells within an organoid drive those differences, or that medium composition causes differences in organoid formation efficiency; the reported normal and tumor establishment efficiencies are similar. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Transcriptomic changes during organoid development or passages can lead to confounding effects known as temporal heterogeneity.

    “Another important factor becomes apparent when looking into transcriptomic changes during organoid development206 or studying gene expression changes during organoid passages35,202. When organoids mimic development, these changes can lead to confounding effects – the temporal heterogeneity.”

    From Organoids (2022) · cites this paper as [202]

    The Results section on gene expression compares organoids from normal, precursor, and tumor tissue; it does not track transcriptomic changes during serial passages. The Discussion says organoids can be passaged, but neither section addresses passage-related confounding or temporal heterogeneity (page numbers unavailable). (LLM, conf=0.74)

    Experimental — accuracy not yet measured
  • Normal and tumor organoid models have been developed from human and mouse pancreas.

    “Recently, normal and tumor organoid models have been developed from both human and mouse pancreas (82, 83).”

    From KRAS mutation in pancreatic cancer (2021) · cites this paper as [82]

  • The organoid system is an accepted ex vivo assay that is reflective of stem cell function in vivo.

    “The organoid system is an accepted ex vivo assay that is reflective of stem cell function in vivo (Boj et al., 2015).”

    From Canonical Wnt Signaling Ameliorates Aging of Intestinal Stem Cells (2017) · cites this paper as Boj et al., 2015

  • Recent technological advancements (e.g. organoid models and conditionally reprogrammed cell lines) have led to a new generation of cancer cell models being derived to allow full representation of the histopathological and molecular diversity of tumours.

    “Furthermore, with recent technological advancements (e.g. organoid models and conditionally reprogrammed cell lines), a new generation of cancer cell models is being derived to allow full representation of the histopathological and molecular diversity of tumours (37–42).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., Gracanin, A., Oni, T., Yu, K. H., van Boxtel, R., Huch, M., Rivera, K. D., Wilson, J. P., Feigin, M. E., Öhlund, D., Handly-Santana, A., Ardito-Abraham, C. M., Ludwig, M., Elyada, E., Alagesan, B., Biffi, G., Yordanov, G. N., Delcuze, B., Creighton, B., Wright, K., Park, Y., Morsink, F. H. M., Molenaar, I. Q., Borel Rinkes, I. H., Cuppen, E., Hao, Y., Jin, Y., Nijman, I. J., Iacobuzio-Donahue, C., Leach, S. D., Pappin, D. J., Hammell, M., Klimstra, D. S., Basturk, O., Hruban, R. H., Offerhaus, G. J., Vries, R. G. J., Clevers, H., & Tuveson, D. A.
Affiliations
  • Royal Netherlands Academy of Arts and Sciences (NL)
  • Cold Spring Harbor Laboratory (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • University Medical Center Utrecht (NL)
  • Johns Hopkins University (US)
Corresponding author
Tuveson, David A.
Venue
Cell
Publisher
Elsevier BV
Published
2015-01
Volume
160
Issue
1-2
Pages
324-338
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2010916968
Cited by
2,150
References
81
Citations by year
2026: 139 · 2025: 216 · 2024: 224 · 2023: 226 · 2022: 241 · 2021: 257 · 2020: 241 · 2019: 184 · 2018: 148 · 2017: 128 · 2016: 92 · 2015: 53
FWCI
44.12
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
  • PubMed Central (acceptedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
Funders
  • U.S. Department of Defense (W81XWH‐13‐PRCRP‐IA, W81XWH, 5P30CA045508, W81XWH-13)
  • Damon Runyon Cancer Research Foundation (5T32CA148056, DRG-2165-13)
  • Memorial Sloan-Kettering Cancer Center
  • Pancreatic Cancer UK (2010 Grant, PCUK-2011 Grant)
  • Wellcome Trust (104151/Z/14/Z, 104151)
  • Cold Spring Harbor Laboratory (1R01CA190092-01, 5P50CA101955-07, 5P30CA045508, 5P30CA45508-26)
  • Kempe Foundation (JCK-1301)
  • Myriad Genetics
  • Weizmann Institute of Science
  • Ministero della Salute
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Vetenskapsrådet (JCK-1301, 5P30CA045508, 537-2013-7277)
  • Kempestiftelserna (JCK-1301)
  • Svenska Läkaresällskapet (SLS-326921, SLS-250831, JCK-1301)
  • Sociedad Española de Oncología Médica
  • National Institutes of Health (W81XWH, W81XWH-13-PRCRP-IA, 2p30ca045508-24, 5P30CA45508-26, 5P30CA45508, CA62924, CA101955, 5U01CA168409-3, 5P30CA045508)
  • University of Texas MD Anderson Cancer Center
  • Stand Up To Cancer
  • National Cancer Institute (5U01CA168409-3, T32CA148056, CA-101955, P20CA101955, P01CA134292, P50CA101955, U10CA180944, 5P30CA045508, F32CA180717, U01CA168409, P30-CA045508, CA134292, P50CA062924, 5P30CA45508-26, P30CA008748, CA 62924, R01CA190092)
  • DOD Peer Reviewed Cancer Research Program
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
pancreatic ductal adenocarcinoma, pancreatic organoids, organoid models, pancreatic carcinogenesis, tumor progression, metastasis, orthotopic transplantation, cryopreservation, gene expression profiling, proteomic profiling, mouse model, human cancer
MeSH terms
Animals, Humans, Mice, Inbred C57BL, Mice, Nude, Models, Biological, Organ Culture Techniques, Organoids, Pancreas, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review